FDA cancer advisers OK ‘major advance’ — individualized cancer therapy – Chicago Sun-Times
|
FDA cancer advisers OK 'major advance' — individualized cancer therapy
Chicago Sun-Times Called CAR–T, it involves removing immune cells from a patient's blood, genetically altering them — in effect, reprogramming them to create an army of cells that can zero in on and destroy cancer cells — and then injecting them back into the patient … |
